Vanta Bioscience share news, announcements and annual reports
BSE: 540729Healthcare ServicesSmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹20.40.
30 Oct: open ₹20.39, high ₹20.39, low ₹20.39
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15 Cr4,396th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 133.90
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.68
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.80
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 750
Vanta Bioscience share news and announcements
251 announcements, routine notices left out, newest first. Page 3 of 6.
Sep 2022
3 Sep · Management
Aug 2022
17 Aug · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Jul 2022
28 Jul · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
13 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2022
23 Jun · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
15 Jun · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
3 Jun · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
May 2022
31 May · Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
24 May · Board meeting
Meeting on 30 May 2022: audited results11 May · Corporate Insolvency Resolution Process (CIRP)-Public Announcement
11 May · Management
Apr 2022
29 Apr · Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal
7 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2022
Feb 2022
Jan 2022
15 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Dec 2021
31 Dec · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly <a href="https://www.bseindia.com/stock-share-price/meetings/voting-results/540729 ....8 Dec · Reg. 34 (1) Annual Report
6 Dec · Meeting
Nov 2021
11 Nov · Results
3 Nov · Board meeting
Meeting on 11 Nov 2021: half yearly results
Oct 2021
14 Oct · Shareholding for the Period Ended September 30, 2021
Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....11 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2021
Aug 2021
26 Aug · Meeting
Jul 2021
13 Jul · Intimation Regarding NABL'S Recommendation To Continue The Biological Testing Accreditation Granted To The Company
5 Jul · Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2021
28 Jun · Results
28 Jun · Results
17 Jun · Board meeting
Meeting on 28 Jun 2021: preferential issue of shares and audited results